Search details
1.
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 30(2): 334-343, 2024 01 17.
Article
in English
| MEDLINE | ID: mdl-37992310
Results
1 -
1
de 1
1
Next >
>>